R&D

Challenges and Future Developments in Antibodies

Challenges and Future Developments in Antibodies

Written by on September 19, 2014 in Antibodies, Research & Development, Uncategorized with 1 Comment

As the Antibody sphere is continuously developing , we took some time out to interview senior executives speaking at the European Antibody Congress 2014 to discuss the key challenges and future developments in antibodies. Download this eBook to hear from the likes of lead representatives from Sutro Biopharma, Quality Assistance, ETH Zurich and Pfizer. The […]

Continue Reading

A look at stem cell medical tourism in Mexico

A look at stem cell medical tourism in Mexico

Written by on September 17, 2014 in Research & Development, Stem Cells 2014 with 0 Comments

As a conference organizer, I’ve been in touch with various scientists and regulators in Mexico who are aware of the advancements made in stem cell therapies and their potential to cure fatal/chronic diseases. Medical tourism in Mexico has been a recurrent topic in these conversations since industry experts feel that this practice is giving the […]

Continue Reading

Drug Discovery

Download Ebook: 5 breakthrough therapies to watch

Download Ebook: 5 breakthrough therapies to watch

Written by on September 23, 2014 in Clinical Trials, Drug Discovery with 0 Comments

The US FDA’s Breakthrough Therapy demands sufficient preliminary clinical evidence to prove a compelling proof-of-concept; for instance the drug must show substantial improvement on a significant clinical endpoint when compared with current therapies. If these criteria are met, the US FDA is able to expedite the development and review of drug candidates that are able […]

Continue Reading

Pharma and Biotech 2014 half-year review released

Pharma and Biotech 2014 half-year review released

Written by on September 16, 2014 in Drug Discovery, Featured on app with 0 Comments

In the recent Pharma & Biotech half-year review 2014, consolidated by Evaluate Pte Ltd and EP Vantage, editors had sum up the sector industry as “volatile”.   Make no mistake There are gains to be made by investing in drug developers, helped along by an M&A frenzy that saw nearly $90 billion of equity swallowed […]

Continue Reading

Clinical Trials

Download Interview: Discussion with Korea’s pharma stakeholder

Download Interview: Discussion with Korea’s pharma stakeholder

    It’s no secret that South Korea is currently a hot bed for clinical trials. This market has been flagged as a solid investment opportunity for the future and early results have not disappointed. We reached out to some industry players active on the Korean pharma scene today to gain their insights on what […]

Continue Reading

‘Manipulated’ Stem Cells: How iPSCs have gone from Nobel Prize research to novel therapy reality

‘Manipulated’ Stem Cells: How iPSCs have gone from Nobel Prize research to novel therapy reality

Written by on September 12, 2014 in Clinical Trials, Featured on app with 0 Comments

First patient to receive induced pluripotent stem cells in Japan to treat macular degeneration – is this a result of their regulatory modifications?   2006 saw the discovery that normal human adult cells could be ‘reprogrammed’ to become stem cells that could adopt the form of any type of cell, from heart to liver to […]

Continue Reading

Manufacturing

Genzyme to Implement Upstream and Downstream Continuous Bioprocess

Genzyme to Implement Upstream and Downstream Continuous Bioprocess

Written by on September 29, 2014 in Manufacturing with 0 Comments

A patent has just been filed by Genzyme for a new technology platform that will integrate upstream and downstream bioprocess, creating a fully continuous process for biologics manufacture. Genzyme’s new patent claims to combine an upstream perfusion system with a dual stage chromatography process to extract biologics. The first purification stage being a multi-column chromatography […]

Continue Reading

Download: Quality by Design: Design Space and Scaling-Up Limitations

Download: Quality by Design: Design Space and Scaling-Up Limitations

Written by on September 2, 2014 in Cell Culture, Manufacturing with 0 Comments

Merck Serono’s Thomas Solacroup joined us at the 4th Annual Cell Culture World Congress with a presentation on ‘Quality by Design: Design Space and Scaling-Up Limitations.’ In his talk, Thomas explored the Quality by Design elements and the benefits and limitations of applying this approach. His slides are available for free download below. Download Thomas Solacroup’s […]

Continue Reading

Regulation & Compliance

UK Stem Cell Initiative approaches 10th anniversary

UK Stem Cell Initiative approaches 10th anniversary

Written by on September 29, 2014 in Featured on app, Regulation and Compliance with 0 Comments

The UK Stem Cell Initiative report was warmly received by the Government in 2005 and provided them with a “clear vision for future endeavour with indicative costs for a strategy to maintain the UK’s position as a world leader in basic research” – nearly 10 years on, how have the recommendations developed? In the Budget […]

Continue Reading

COFEPRIS Presents the Case of Mexico

COFEPRIS Presents the Case of Mexico

Written by on September 4, 2014 in Featured on app, Regulation and Compliance, Reports with 0 Comments

Mikel Arriola was born in Mexico City and was appointed Federal Commissioner for Protection from Sanitary Risks on March, 2011. He studied Law at the Universidad Anáhuac as a Bachelor Degree, has a Master Degree on Public Policy and Public Administration by the London School of Economics and Political Science of London, United Kingdom and […]

Continue Reading

Pricing & Market Access

Download ebook: Top Market Access Services Required by BioPharma

Download ebook: Top Market Access Services Required by BioPharma

Written by on September 26, 2014 in Pricing & Market Access, Reports with 0 Comments

Pharmaceutical market access is not easy. It can seem fickle, lengthy and very complicated. Ensuring that your medicines get to the patients that need them involves dealing with clinicians, payers, HTA bodies and internal and external stakeholders. Just as you think you understand the rules of the game, they change. Value based pricing anyone? It […]

Continue Reading

Download: A Pharma Prospective On CER And How It Can Aid Payer Coverage Policies

Download: A Pharma Prospective On CER And How It Can Aid Payer Coverage Policies

Written by on September 24, 2014 in Featured on app, Pricing & Market Access, Reports with 0 Comments

At Market Access USA 2013, Keith Huff, PharmD, MS gave a presentation on “A Pharma Prospective On Comparative Effectiveness Research And How It Can Aid Payer Coverage Policies” Download the presentation to learn: Needs of the Payer Needs of Pharma Comparative Effectiveness Research How is CER used Needs for credible CER studies Challenges in CER […]

Continue Reading

Engagement & Marketing

Download whitepaper: Managing the Marketing Gap

Download whitepaper: Managing the Marketing Gap

Written by on September 26, 2014 in Engagement & Communications with 0 Comments

  A Navigation Guide for the New Era of Insight-Driven Marketing This white paper is intended for senior brand management and therapeutic area leadership roles, as well as commercial operations teams that provide tools, processes, and other capabilities to enable marketing efforts. Marketing is undergoing a wide-scale transformation to enable individual customer driven interactions, automated cross-channel campaign management, and […]

Continue Reading

Clinical, moral and compliance dilemmas in health app development

Clinical, moral and compliance dilemmas in health app development

Written by on September 24, 2014 in Engagement & Communications with 0 Comments

Nick Broughton, Managing Director of Pharmaceuticalethics.com gives his presentation on ‘Clinical, moral and compliance dilemmas in health app development’ at DigiPharm 2013.  Watch the full video. Interested in learning more?  Join us at Pharma Engagement Live 2014, held this 7-8 October in London at the Business Design Centre.  Explore the issues involved in engaging, supporting and […]

Continue Reading

Partnering & Investment

Promising scale and market success for cell therapies after large financial injection

Promising scale and market success for cell therapies after large financial injection

Written by on September 19, 2014 in Featured on app, Partnering & Investment with 0 Comments

In a report released this week, by BCC Research, it was forecasted that the global market for stem cells (including cell therapies) is to reach US $10.6 billion in 2018. However with currently no medicines, based on stem cells, having yet received marketing authorisation from the EMA*, or the FDA*, how are we going to get there? […]

Continue Reading

An investor perspective and analysis of the stem cell & regenerative medicine sector

An investor perspective and analysis of the stem cell & regenerative medicine sector

Written by on September 12, 2014 in Partnering & Investment, Regenerative Medicine with 0 Comments

Dr. Navid Malik B.Sc. M.Sc. MBA, Cenkos joined us at the 9th Annual World Stem Cells & Regenerative Medicine Congress to present on ‘An investor perspective and analysis of the stem cell & regenerative medicine sector’ Download this presentation now to find out: Cenkos Securities’ focus on Life Sciences Longer-term sector returns have been very […]

Continue Reading

Other Recent Posts

What Does Shire Mexico Have to Say About Orphan Drugs?

We’re excited to announce that Raul Vivar, General Director of Shire Mexico, will be speaking at this year’s BioPharma Mexico. Raul’s presentation is titled “Accessing public institutions: A success story changing the lives of lysosomal disease patients”, and will take place at 4:05 pm on Wednesday, November 5th. Don’t miss it! Download our interview with […]

Continue Reading

Are we ever going to see online appointments for GPs?

Knowing I’m working on a digital health event, this was the question fired to me in frustration by my colleague Danny earlier today. He’d been sat on hold for ten minutes trying to make a doctor’s appointment for a routine check-up. He works in the aviation industry where he can book a flight, hotel and […]

Continue Reading

Cinvestav on obtaining bio-equivalency for biotech development

We were excited to have Gilberto Castañeda, Principal Investigator of the Pharmacology Department at the Centro de Investigación y Estudios Avanzados-IPN, speak at last year’s BioPharma Mexico. Gilberto is a principal investigator in the Department of Pharmacology at the Center for Research and Advanced Studies of the National Polytechnic Institute (IPN). He received a Ph.D. […]

Continue Reading

¿Qué Dice Shire Sobre los Medicamentos Huérfanos en México?

Es un placer contar con la participacion de Raúl Vivar, Director General de Shire México, como uno de nuestros ponentes en BioPharma México 2014. Raúl hablará sobre El acceso a instituciones de salud públicas: Una historia de éxito cambiando la vida de pacientes con enfermedades lisosomales, el miércoles, 5 de noviembre a las 16.05 de […]

Continue Reading

Download: Payer Engagement and Preparing Information to Support Value Proposition

Demonstrate value and improve payer engagement with tips from Jorge Arellano, MSc, MPhil, Director Global Health Economics, Amgen. In his presentation, given at Evidence USA 2013, he discusses these topics and more. Download to learn: Evidence Generation: The Process Evidence Generation: Key Deliverables Payers input Understanding Your Payer(s) Download presentation Discover how pharma, payers and […]

Continue Reading

Top
Geolocation